16
Total deals
$115.7B
Total value
$11.6B
Avg deal
$86.4B
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
N
Nimbus Lakshmi
Nimbus Lakshmi operates as a wholly-owned subsidiary of Nimbus Therapeutics and …
|
2022-12-13 | Acquisition | Complete | — | Deal → |
| 2 |
Adaptate Biotherapeutics
Adaptate is a biotherapeutics company that develops antibodies to modulate gamma…
|
2022-01-10 | Acquisition | Complete | — | Deal → |
| 3 |
Maverick Therapeutics
Maverick Therapeutics is a biotech company focused on improving the lives of pat…
|
2021-03-09 | Acquisition | Complete | — | Deal → |
| 4 |
PvP Biologics
PvP Biologics is developing an oral enzyme for the treatment of celiac disease.
|
2020-02-26 | Acquisition | Complete | $330.0M | Deal → |
| 5 |
Shire
Shire biotechnology company that focuses on serving people with rare diseases.
|
2018-04-25 | Acquisition | Complete | $86.4B | Deal → |
| 6 |
TiGenix
TiGenix is a biomedical company focused on research and development of innovativ…
|
2018-01-05 | Acquisition | Complete | $625.5M | Deal → |
| 7 |
ARIAD Pharmaceuticals
ARIAD is a global oncology company focused on the discovery, development and com…
|
2017-01-09 | Acquisition | Complete | $5.2B | Deal → |
| 8 |
Inviragen
Inviragen is focused on developing life-saving vaccines to protect against emerg…
|
2013-05-07 | Acquisition | Complete | — | Deal → |
| 9 |
Envoy Therapeutics
Envoy Therapeutics is a drug discovery company focused on developing novel drugs…
|
2012-11-06 | Acquisition | Complete | — | Deal → |
| 10 |
LigoCyte Pharmaceuticals
LigoCyte Pharmaceuticals is focused on developing vaccines and monoclonal antibo…
|
2012-10-05 | Acquisition | Complete | $60.0M | Deal → |
| 11 |
Intellikine
Intellikine is focused on the R&D of orally available small molecule drugs targe…
|
2011-12-21 | Acquisition | Complete | $310.0M | Deal → |
| 12 |
Nycomed Pharma
Nycomed is a privately owned global pharmaceutical company with a diversified po…
|
2011-05-19 | Acquisition | Complete | $13.7B | Deal → |
| 13 |
IDM Pharma
IDM develops immunotherapies for cancer
|
2009-05-18 | Acquisition | Complete | $75.0M | Deal → |
| 14 |
Takeda Bio Development Center
Engages in the development of human therapeutics.
|
2008-02-01 | Acquisition | Complete | — | Deal → |
| 15 |
Millennium Pharmaceuticals
Millennium Pharmaceuticals is a biopharmaceutical company that supplies biopharm…
|
2008-02-01 | Acquisition | Complete | $8.7B | Deal → |
| 16 |
Syrrx
Syrrx, Inc. is a drug discovery company committed to redefining the way medicine…
|
2005-02-07 | Acquisition | Complete | $270.0M | Deal → |